Search Main menu

Has the HPV vaccine program been successful?

Almost all Australian schools participate in the National Immunisation Program.

Research studies have documented the vaccine's success in Australia including:

  • a 92% reduction in HPV types responsible for almost 75% of cervical cancer

  • 70% reduction in the incidence of high-grade cervical abnormalities in women under 20, a 50% reducation in women 20–24 and 19% reduction in women 25–29 by 2017

  • a 93% reduction in genital warts in heterosexual men and women under 21 years of age and an 80% reduction in 21–30 year old females and 72% reduction in 21–30 year old males

  • the near disappearance of a rare but severe disease of the throat and airways in children called juvenile onset recurrent respiratory papillomatosis. This condition is caused by the same types of HPV that can cause genital warts.
Change text size : A -   A +  

There has already been a reduction in the number of young women with high-grade abnormalities in cells of the cervix.

Design and partial content reproduced with the kind permission of the New Zealand Ministry of Health.

The HPV vaccine is a prescription medicine. Medicines have benefits and risks. After reading this website, talk to your doctor about the benefits and risks of this vaccine and to check eligibility.

Females who have had the HPV vaccine still need regular Cervical Screening Tests.